novo nordisk semaglutide pill shares slide after Ozempic fails in Alzheimer's trials | Pharmaceuticals industry Novo Nordisk's weight-loss pill wins

Administration of isoliquiritigenin prevents nonalcoholic fatty liver disease through a novel IQGAP2CREBSIRT1 axis

K., Lim S., Jang H

Mexico s COFEPRIS shut down five pharmacies in Playa del Carmen for selling adulterated and controlled medications to foreign tourists

GLP-1R AMPK SIRT1

A rise of more than 0.75 ng/mL per year (annualized from the 12-week interval) exceeds the expected biological variation and warrants urologic referral, independent of the absolute value

No matter your reason for taking a GLP-1whether for blood sugar control, weight management, or to reduce the risk of heart diseaseits possible to develop a sick-to-the-stomach feeling while on the drug